Korean J Dermatol.  2022 Feb;60(2):130-134.

Two Cases of Lymphomatoid Papulosis Mimicking Pseudolymphoma Successfully Treated with Low-Dose Methotrexate and 308-nm Ultraviolet Laser Therapy

Affiliations
  • 1Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea

Abstract

Lymphomatoid papulosis (LyP) is a CD30+ lymphoproliferative disorder characterized by chronic papulonodular eruptions. Highly potent topical steroids and phototherapy are the first-line modalities, and low-dose methotrexate (MTX) combined with folic acid is known to be safe and efficient for the treatment of LyP. However, there are concerns about whether whole-body phototherapy should be performed for limited lesions. Herein, we report the first case series of localized LyP mimicking pseudolymphoma successfully treated with low-dose MTX and 308 nm ultraviolet (UV) laser therapy. Clinicians should consider UV laser therapy as a novel treatment option because it has the advantage of selective treatment.

Keyword

Lymphomatoid papulosis; Methotrexate; Phototherapy; Pseudolymphoma; Ultraviolet therapy
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr